NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 25 filers reported holding NEUBASE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $105,000 | -44.1% | 100,000 | 0.0% | 0.00% | – |
| Q1 2022 | $188,000 | -33.1% | 100,000 | 0.0% | 0.00% | – |
| Q4 2021 | $281,000 | -22.2% | 100,000 | 0.0% | 0.00% | – |
| Q3 2021 | $361,000 | -24.6% | 100,000 | 0.0% | 0.00% | – |
| Q2 2021 | $479,000 | +457.0% | 100,000 | +754.7% | 0.00% | – |
| Q1 2021 | $86,000 | -3.4% | 11,700 | -8.0% | 0.00% | – |
| Q4 2020 | $89,000 | +20.3% | 12,723 | +30.7% | 0.00% | – |
| Q3 2020 | $74,000 | -5.1% | 9,735 | +9.5% | 0.00% | – |
| Q2 2020 | $78,000 | +105.3% | 8,890 | +64.3% | 0.00% | – |
| Q4 2019 | $38,000 | – | 5,410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CARNEGIE MELLON UNIVERSITY | 46,970 | $40,855 | 0.05% |